Categories
Femoropopliteal Disease
Are there specific duplex criteria for the surveillance of intra inguinal arterial stents, and if so, what are they?
Keith Calligaro, MD | 2020 Annual Meeting
Subintimal Recanalization of Chronically Occluded Superficial Femoral and Popliteal Artery Stents Using Interwoven Nitinol Stents
Michael Siah, MD | 2020 Annual Meeting
The Global Anatomic Staging System Does Not Predict Patency of Tibial Endovascular Interventions
Caitlin Hicks, MD | 2020 Annual Meeting
Patients with Failed Femoropopliteal Covered Stents are More Likely to Present with Acute Limb Ischemia than Those with Failed Femoropopliteal Bare-Metal Stents
Charles DeCarlo, MD | 2020 Annual Meeting
Stenting of popliteal lesions performs superior to drug coated balloon angioplasty
Karim Salem, MD | 2020 Annual Meeting
Are the Reported Advantages of Pacitaxil Therapy worth the potential risks?
Darren Schneider, MD | 2020 Annual Meeting
Paclitaxel: Friend or Foe…Data Driven Decision Making (Sponsored by Boston Scientific)
Michael Jaff, DO | 2020 Annual Meeting
Propensity-Matched Analysis of Patients Treated with Paclitaxel-Coated Versus Uncoated Balloons
Alexander King, MS | 2020 Annual Meeting
Contemporary Outcomes for Redo Autogenous Infrainguinal Bypass
Rui Han Liu, MD | 2018 Annual Meeting
Drug Coated Balloon Angioplasty Confers No Advantage In The Treatment Of Femoropopliteal Disease When Stenting Is Required
Kathleen Ozsvath, MD | 2018 Annual Meeting